+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease



Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease



Ugeskrift for Laeger 158(42): 5957-5962




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045363774

Download citation: RISBibTeXText

PMID: 8928288


Related references

Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?. Drugs and Aging 24(8): 615-628, 2007

Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 1(3): 200-206, 2005

Do children with acute asthma benefit more from anticholinergics and beta2 agonists than from beta2 agonists alone?. American Family Physician 66(3): 417-418, 2002

Is Combination Therapy with Inhaled Anticholinergics and β2-Adrenoceptor Agonists Justified for Chronic Obstructive Pulmonary Disease?. Drugs & Aging 24(8): 615-628, 2007

Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001(2): Cd002984, 2001

Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD). Pneumologie 62(7): 430-437, 2008

Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma. Respirology 2 Suppl 1: S5-10, 1997

Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews 2000(4): Cd000060, 2000

Inhaled long-acting β-agonists versus anticholinergics in older patients with chronic obstructive pulmonary disease. Annals of Internal Medicine 155(8): 561; Author Reply 561-2, 2011

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup. Journal of Medicinal Chemistry 53(18): 6640-6652, 2010

Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ 317(7164): 971-977, 1998

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews 2014(8): Cd000060, 2014

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Paediatric Respiratory Reviews 14(4): 234-235, 2014

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 1: Cd010139, 2017

Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2000(2): Cd001104, 2000